Skip to Content

Dextromethorphan / promethazine Pregnancy and Breastfeeding Warnings

Dextromethorphan / promethazine is also known as: Phenergan with Dextromethorphan, Promethazine DM, Promethazine with DM, Promethazine with Dextromethorphan

Dextromethorphan / promethazine Pregnancy Warnings

Rat feeding studies with promethazine at doses of 2.1 to 4.2 times the maximum recommended human dose have failed to reveal evidence of teratogenicity, but daily intraperitoneal doses of 25 mg/kg have produced fetal mortality in rats. Although antihistamines have produced fetal mortality in rodents, the pharmacological effects of histamine in the rodent do not parallel those in man. There are no controlled data in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Benefit should outweigh risk US FDA pregnancy category: C Comments: -Promethazine administered 2 weeks prior to delivery may inhibit platelet aggregation in the newborn. -Many cough syrups contain alcohol, be sure to check labels and avoid alcohol containing products.

See references

Dextromethorphan / promethazine Breastfeeding Warnings

Based on the low molecular weight of dextromethorphan some passage into breast milk probably occurs. However, maternal use of dextromethorphan products that do not contain alcohol are probably safe to use during breast-feeding. Phenothiazine derivatives are minimally excreted in breastmilk; although specific data on excretion of promethazine is not available. A less potent histamine blocking is generally preferred in nursing mothers.

Benefit should outweigh risk Excreted into human milk: Unknown (dextromethorphan); Unknown (promethazine) Excreted into animal milk: Data not available (dextromethorphan); Data not available (promethazine) Comments: -Many cough syrups contain alcohol, be sure to check labels and avoid alcohol containing products. -Promethazine can inhibit prolactin release and may interfere with lactation.

See references

References for pregnancy information

  1. "Product Information. Promethazine DM (dextromethorphan-promethazine)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc), Huntsville, AL.

References for breastfeeding information

  1. "Product Information. Promethazine DM (dextromethorphan-promethazine)." Par Pharmaceutical Inc (formerly Qualitest Pharmaceuticals Inc), Huntsville, AL.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide